Sen. Committee Clears Drug Disclosure, Biosimilar Bills
The U.S. Senate Committee on Health, Education, Labor and Pensions on Wednesday cleared two bills for full Senate review, tackling the gap between health and patent oversight agencies, and the need...To view the full article, register now.
Already a subscriber? Click here to view full article